168 related articles for article (PubMed ID: 29434961)
1. Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide-induced autophagic death of U251 glioma cells.
Li B; Zhou C; Yi L; Xu L; Xu M
Oncol Lett; 2018 Feb; 15(2):2477-2484. PubMed ID: 29434961
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line.
Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC
Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin 1 and inhibiting autophagy.
Xu J; Huang H; Peng R; Ding X; Jiang B; Yuan X; Xi J
Exp Ther Med; 2018 Jun; 15(6):4798-4804. PubMed ID: 29805498
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
5. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells.
Wang N; Zhang Q; Luo L; Ning B; Fang Y
J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671
[TBL] [Abstract][Full Text] [Related]
6. Effect of silencing S-phase kinase-associated protein 2 on chemosensitivity to temozolomide of human glioma cells U251.
Liu Y; Tang ZG; Yang JQ; Zhou Y; Lin Y; Lv W; Wang GB; Li CL
Am J Transl Res; 2019; 11(4):2470-2476. PubMed ID: 31105854
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.
Shi L; Li H; Zhan Y
Oncol Lett; 2017 Sep; 14(3):2709-2714. PubMed ID: 28927033
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.
Gao S; Yang XJ; Zhang WG; Ji YW; Pan Q
Chin Med J (Engl); 2009 Jun; 122(11):1260-6. PubMed ID: 19567134
[TBL] [Abstract][Full Text] [Related]
9. Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells.
Li G; Zhang H; Liu Y; Kong L; Guo Q; Jin F
Exp Ther Med; 2015 Mar; 9(3):744-750. PubMed ID: 25667622
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
11. Differential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.
Коbylinska LI; Klyuchivska OY; Grytsyna II; Finiuk N; Panchuk RR; Starykovych MO; Lehka L; Lesyk RB; Zіmenkovsky BS; Stoika RS
Croat Med J; 2017 Apr; 58(2):150-159. PubMed ID: 28409498
[TBL] [Abstract][Full Text] [Related]
12. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
Wang N; Zhang Q; Ning B; Luo L; Fang Y
Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.
Zhang ZS; Wang J; Shen YB; Guo CC; Sai KE; Chen FR; Mei X; Han FU; Chen ZP
Oncol Lett; 2015 Jul; 10(1):379-383. PubMed ID: 26171034
[TBL] [Abstract][Full Text] [Related]
14. [Toxic effects of Vitamin C combined with temozolomide on glioma cells and its mechanism].
Chen MS; Zhao HK; Cheng YY; Yuan ZH; Zhang YL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Nov; 36(6):616-621. PubMed ID: 33719269
[No Abstract] [Full Text] [Related]
15. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of temozolomide-induced antitumour effects on glioma cells.
Shen W; Hu JA; Zheng JS
J Int Med Res; 2014 Feb; 42(1):164-72. PubMed ID: 24326954
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
[TBL] [Abstract][Full Text] [Related]
18. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
